Opinion|Videos|October 2, 2024
Bridging the Gap: Key Considerations for Physicians Interpreting Gallium-Based PET Imaging
Author(s)Jaideep S. Sohi, MD, Jeremie Calais, MD
Key opinion leaders offer insights on closing knowledge gaps and highlight crucial factors for physicians to consider when interpreting gallium-based PET imaging results in clinical practice.
Advertisement
Video content above is prompted by the following:
- What key aspects of gallium-based PET imaging should physicians interpreting other modalities understand, and what advice do you have to address any unfamiliar nuances or challenges they may encounter?
Advertisement
Related to this article
Uptunity | Aneurysm reportedly identifies suspected saccular brain aneurysms larger than 3 mm on head CTA and provides quantitative comparison between exams to assess changes in known aneurysms over time.
Through enhanced insights into atherosclerotic disease, complex coronary lesions and coronary stents, photon-counting CT provides an anatomical roadmap that may improve outcomes for interventional procedures.
The PSMA PET radiopharmaceutical 64Cu-SAR-bisPSMA, which previously garnered two FDA fast track designations, more than doubled the detection of PCa lesions in comparison to 68Ga-PSMA-11 in the phase II Co-PSMA trial.
The mobile X-Ray unit DR 100s Pro reportedly offers an array of attributes to facilitate workflow efficiencies and quality imaging.
In comparison to the RECIST 1.1 criteria, use of the mpMRI-based NacBI-RADS system for evaluating response to neoadjuvant chemotherapy (NAC) for breast cancer offered an 8 percent higher sensitivity and over 26 percent higher specificity.
A high glandular tissue component on pre-op breast ultrasound may significantly elevate the risk of recurrence for ipsilateral or contralateral breast cancer, according to a newly published study.
Effective January 1, 2027, use of the QTscan in outpatient diagnostic exams will be reimbursable with the CPT code 1079T.
In a recent interview, Carolynn DeBenedectis, MD, discussed the utility of AI-enabled slab reconstruction for interpretation of digital breast tomosynthesis (DBT) and new research showing a 13 percent reduction in reading time.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears CTA-Based AI Software for Brain Aneurysm Detection and Follow-Up
2
Will PCCT Lead the Next Revolution in Interventional Cardiology?
3
FDA Issues Breakthrough Therapy Designation for Emerging PSMA PET Agent in Men with Suspected PCa Recurrence
4
Agfa Radiology to Introduce AI-Powered DR 100s Pro X-Ray Platform at RSNA
5